Director

Sri Kosaraju

Director·10x Genomics, Inc.

About

Sri Kosaraju has served on the 10x Genomics board of directors since April 2019.

Since January 2026 he has served as a global chair of investment banking for JPMorgan Chase & Co. supporting the firm's healthcare industry vertical. He was President and CEO of Inscripta from October 2020 to April 2025, when it merged with Manus Bio. Earlier he was President of Penumbra (August 2019-May 2020), its CFO (May 2015-November 2019) and Head of Strategy, and before that spent 16 years in investment banking at J.P. Morgan, ultimately as Managing Director of Equity Capital Markets and Head of Healthcare Equity Capital Markets.

He received a B.S. from the Massachusetts Institute of Technology in 1999.

Since 2019
Age 48
Tenure 7 yrs

Also at 10x Genomics, Inc.

SS Serge Saxonov Chief Executive Officer and Director BH Benjamin J. Hindson Chief Scientific Officer, President and Director JS John R. Stuelpnagel Chairman of the Board of Directors AM Alan Mateo Director KP Kimberly J. Popovits Director ST Sarah Teichmann Director

Roles

Organization Role Dates Details
10x Genomics, Inc. Director 2019–present Current role
Inscripta President and Chief Executive Officer October 2020 - April 2025 Merged with Manus Bio in April 2025.
Penumbra President August 2019 - May 2020 Publicly traded medical device company.
Penumbra Chief Financial Officer May 2015 - November 2019
Penumbra Head of Strategy May 2015 - August 2019
J.P. Morgan Securities LLC Investment banking, including Managing Director of Equity Capital Markets and Head of Healthcare Equity Capital Markets 1999 - May 2015 Equity Capital Markets group from 2006; Equity Derivatives 2003-2006; Technology, Media, Telecom Investment Banking Coverage 1999-2003.

External roles

Organization Role Dates
JPMorgan Chase & Co. Global chair of investment banking (healthcare vertical) January 2026 -
Manus Bio Director April 2025 -
Nevro Corp. Director August 2021 - April 2025
Hertz Foundation Director October 2025 -

Related

Company 10x Genomics, Inc. Company hub Person Serge Saxonov Chief Executive Officer and Director Person Benjamin J. Hindson Chief Scientific Officer, President and Director Person John R. Stuelpnagel Chairman of the Board of Directors Person Alan Mateo Director Person Kimberly J. Popovits Director Person Sarah Teichmann Director Person Shehnaaz Suliman Director Person Adam S. Taich Chief Financial Officer Person Randy Wu General Counsel and Secretary Person Eric S. Whitaker Strategic Counsel (former Chief Legal Officer)
Source: 10x Genomics, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo